معرفی
Amanda Hudson is a Sydney Vital Fellow affiliated with the Bill Walsh Translational Cancer Research Laboratory at the Kolling Institute, University of Sydney. She works within the Sydney Medical School Northern and is associated with the Northern Sydney Local Health District. Her research focuses on cancer biology, brain tumours, immunotherapy, and mesothelioma, with a particular emphasis on translational models and therapeutic development.
- Email: amanda.hudson@sydney.edu.au
- Contact: +61 2 9926 4722 | +61 2 9926 4035 (Fax)
Research Themes: Cancer biology, immuno-suppressive microenvironment, inflammation-coagulation interactions in glioma, and drug resistance mechanisms. She utilizes animal models and translational research approaches to study brain cancers and chemotherapy-resistant tumors.
Scientific Awards: Includes Sydney Vital Fellowships, Brain Cancer Group grants, and NHMRC-supported clinical trials. Her funding focuses on modulating inflammation, targeting hypoxia, and developing novel therapeutics for brain cancer.
Publications span glioblastoma recurrence dynamics, immunotherapy in mesothelioma, biomarker discovery in pancreatic cancer, and radiation therapy optimization. Her work bridges preclinical models (e.g., murine Gl261 glioma) with clinical applications.
Collaborations: Partners with institutions like the Kolling Institute and Brain Cancer Group Limited, leveraging multidisciplinary teams to advance cancer treatments.
